Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011–2012 (original) (raw)

References

  1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–31.
    Article CAS PubMed Google Scholar
  2. Sung KC, Ryan MC, Wilson AM. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects. Atherosclerosis. 2009;203:581–6.
    Article CAS PubMed Google Scholar
  3. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol. 2003;38:954–61.
    Article PubMed Google Scholar
  4. Omagari K, Morikawa S, Nagaoka S, Egawa I, Sawa T, Hazama H, et al. Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics. J Gastroenterol Hepatol. 2002;17:1098–105.
    Article PubMed Google Scholar
  5. Eguchi Y, Hyogo H, Ono M, Mizuta T, Ono N, Fujimoto K, JSG-NAFLD, et al. Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol. 2012;47:586–95.
    Article CAS PubMed Google Scholar
  6. Committee for diagnostic criteria of Metabolic Syndrome. The definition and diagnostic criteria of Metabolic Syndrome (In Japanese). J Jpn Soc Int Med. 2005;94:794–809.
    Article Google Scholar
  7. A standard Health Checkup and Health Guidance Program (In Japanese). Health Department of the Ministry of Health, Labor and Welfare, Japan. 2007.
  8. International Obesity Task Force. The Asian-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia Pty Limited; 2000.
    Google Scholar
  9. Kashiwagi A, Kasuga M, Arai E, Oka Y, Hanafusa T, Ito H, et al. International clinical harmonization of glycated hemoglobin in Japan. From Japan Diabetes Society to National Glycohemoglobin Standardization Program Values. Diabetol Int. 2012;3:8–10.
    Article Google Scholar
  10. Kim HJ, Kim HJ, Lee KE, Kim DJ, Kim SK, Ahn CW, Lim SK, et al. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults. Arch Intern Med. 2004;164:2169–75.
    Article PubMed Google Scholar
  11. Pagadala MR, McCullough AJ. Non-alcoholic fatty liver disease and obesity: not all about body mass index. Am J Gastroenterol. 2012;107:1859–61.
    Article PubMed Google Scholar
  12. Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology. 2010;51:1593–602.
    Article CAS PubMed Google Scholar
  13. Younossi ZM, Stepanova M, Negro F, Hallaji S, Younossi Y, Lam B, Srishord M. Nonalcoholic fatty liver disease in lean individuals in the United States. Medicine (Baltimore). 2012;91:319–27.
    Article Google Scholar
  14. Kwon YM, Oh SW, Hwang SS, Lee C, Kwon H, Chung GE. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am J Gastroenterol. 2012;107:1852–8.
    Article CAS PubMed Google Scholar
  15. Chen CH, Huang MH, Yang JC, Nien CK, Yang CC, Yeh YH, Yueh SK. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults. J Clin Gastroenterol. 2006;40:745–52.
    Article CAS PubMed Google Scholar
  16. Xu C, Yu C, Ma H, Xu L, Miao M, Li Y. Prevalence and risk factors for the development of nonalcoholic Fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai study. Am J Gastroenterol. 2013;108:1299–304.
    Article PubMed Google Scholar
  17. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005;143:722–8.
    Article CAS PubMed Google Scholar
  18. Chang Y, Ryu S, Sung E, Woo HY, Cho SI, Yoo SH, et al. Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men. Gut. 2009;58:1419–25.
    Article CAS PubMed Google Scholar
  19. Saida T, Fukushima W, Ohfuji S, Kondo K, Matsunaga I, Hirota Y. Effect modification of body mass index and body fat percentage on fatty liver disease in a Japanese population. J Gastroenterol Hepatol. 2013;. doi:10.1111/jgh.12377.
    Google Scholar
  20. Johnson NA, Keating SE, George J. Exercise and the liver: implications for therapy in fatty liver disorders. Semin Liver Dis. 2012;32:65–79.
    Article CAS PubMed Google Scholar
  21. Dunn W, Xu R, Schwimmer JB. Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology. 2008;47:1947–54.
    Article PubMed Google Scholar
  22. Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, Urabe A. Light and moderate alcohol consumption significantly reduces the prevalence of fatty liver in the Japanese male population. Am J Gastroenterol. 2009;104:2189–95.
    Article PubMed Google Scholar
  23. Davies MJ, Baer DJ, Judd JT, Brown ED, Campbell WS, Taylar PR. Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women: a randomized controlled trial. JAMA. 2002;287:2559–62.
    Article CAS PubMed Google Scholar
  24. Hamabe A, Uto H, Imamura Y, Kusano K, Mawatari S, Kumagai K, et al. Impact of cigarette smoking on onset of nonalcoholic fatty liver disease: a 10-year longitudinal study. J Gastroenterol. 2011;46:769–78.
    Article CAS PubMed Google Scholar
  25. Ohkuma T, Fujii H, Iwase M, Kikuchi Y, Ogata S, Idewaki Y, Ide H, et al. Impact of eating rate on obesity and cardiovascular risk factors according to glucose tolerance status: the Fukuoka Diabetes Registry and the Hisayama Study. Diabetologia. 2013;56:70–7.
    Article CAS PubMed Google Scholar
  26. Eguchi Y, Eguchi T, Mizuta T, Ide Y, Yasutake T, Iwakiri R, et al. Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease. J Gastroenterol. 2006;41:462–9.
    Article CAS PubMed Google Scholar
  27. Eguchi Y, Mizuta T, Sumida Y, Ishibashi E, Kitajima Y, Isoda H, et al. The pathological role of visceral fat accumulation in steatosis, inflammation, and progression of nonalcoholic fatty liver disease. J Gastroenterol. 2011;46:70–8.
    Article CAS PubMed Google Scholar
  28. van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, Kench JG, et al. Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology. 2008;48:449–57.
    Article PubMed Google Scholar
  29. Imamura Y, Uto H, Oketani M, Hiramie Y, Hosoyamada K, Sho Y, et al. Association between changes in body composition an d the increasing prevalence of fatty liver in Japanese men. Hepatol Res. 2008;38:1083–6.
    Article CAS PubMed Google Scholar
  30. Joseph AE, Saverymuttu SH, al-Sam S, Cook MG, Maxwell JD. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991;43:26–31.
    Article CAS PubMed Google Scholar
  31. Friedman GD, Collen MF, Fireman BH. Multiphasic health checkup evaluation: a 16-year follow-up. J Chronic Dis. 1986;39:453–63.
    Article CAS PubMed Google Scholar
  32. Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N. Soft drinks consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol. 2009;51:918–24.
    Article CAS PubMed Google Scholar
  33. Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology. 2003;37:909–15.
    Article CAS PubMed Google Scholar
  34. Solga S, Alkhuraishe AR, Clark JM, Torbenson M, Greenwald A, Diehl AM, Magnuson T. Dietary composition and nonalcoholic fatty liver disease. Dig Dis Sci. 2004;49:1578–83.
    Article PubMed Google Scholar
  35. Yasutake K, Nakamuta M, Shima Y, Ohyama A, Masuda K, Haruta N, et al. Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol. Scand J Gastroenterol. 2009;44:471–7.
    Article CAS PubMed Google Scholar
  36. McCarthy EM, Rinella ME. The role of diet and nutrient composition in nonalcoholic fatty liver disease. J Acad Nutr Diet. 2012;112:401–9.
    Article CAS PubMed Google Scholar
  37. Vega GL, Chandalia M, Szczepaniak LS, Grundy SM. Metabolic correlates of nonalcoholic fatty liver in women and men. Hepatology. 2007;46:716–22.
    Article CAS PubMed Google Scholar
  38. Korenblat KM, Fabbrini E, Mohammed BS, Klein S. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology. 2008;134:1369–75.
    Article CAS PubMed Central PubMed Google Scholar
  39. Jimba S, Nakagami T, Takahashi M, Wakamatsu T, Hirota Y, Iwamoto Y, et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabetes Med. 2005;22:1141–5.
    Article CAS Google Scholar

Download references